Etude de l'effet immunodépresseur des composés chimiques utilisés en chimiothérapie anticancéreuse

J. L. Amiel, M. Sekiguchi, G. Daguet, S. Garattini, V. Palma

Research output: Contribution to journalArticle

Abstract

The immuno-depressive effect of several compounds: antipurines, antifolics, antipyrimidines, alkylating agents, periwinkle alcaloids, mitomycin C, actinomycin D, puromycin, chloramphenicol, methylhydrazine, imidazoline terephtalanilide, methyl-glyoxal-bis (guanydrazone), epsilon-amino-caproic acid, has been studied in mice by a test including three different antigenic stimuli (human albumen, poliovirus, graft of allogenic skin). They were administered at an infralethal dose, related to the lethal dose in 6 days. The treatment lasted 20 days, ending or beginning on the antigenic day. The results show that, at equal toxicity, the different drugs tested have quite different immuno-depressive activities. Those which interfere with the DNA synthesis (antipurines, antifolics, mitomycin C) are particularly active when given before the antigenic stimulus, while cyclophosphamide and methyl-hydrazine are especially active after the antigenic stimulus. These results are discussed in relation with the mechanism of immuno-suppression by these products. The indications derived from these results concerning immuno-depressive treatments in Man, and destined at obtaining and maintaining tolerance to incompatible grafts and transplants, are considered.

Original languageFrench
Pages (from-to)47-65
Number of pages19
JournalEuropean Journal of Cancer (1965)
Volume3
Issue number1
Publication statusPublished - Feb 1967

Cite this

Etude de l'effet immunodépresseur des composés chimiques utilisés en chimiothérapie anticancéreuse. / Amiel, J. L.; Sekiguchi, M.; Daguet, G.; Garattini, S.; Palma, V.

In: European Journal of Cancer (1965), Vol. 3, No. 1, 02.1967, p. 47-65.

Research output: Contribution to journalArticle

@article{518692a23d71474d951f47a5c0b4ec18,
title = "Etude de l'effet immunod{\'e}presseur des compos{\'e}s chimiques utilis{\'e}s en chimioth{\'e}rapie anticanc{\'e}reuse",
abstract = "The immuno-depressive effect of several compounds: antipurines, antifolics, antipyrimidines, alkylating agents, periwinkle alcaloids, mitomycin C, actinomycin D, puromycin, chloramphenicol, methylhydrazine, imidazoline terephtalanilide, methyl-glyoxal-bis (guanydrazone), epsilon-amino-caproic acid, has been studied in mice by a test including three different antigenic stimuli (human albumen, poliovirus, graft of allogenic skin). They were administered at an infralethal dose, related to the lethal dose in 6 days. The treatment lasted 20 days, ending or beginning on the antigenic day. The results show that, at equal toxicity, the different drugs tested have quite different immuno-depressive activities. Those which interfere with the DNA synthesis (antipurines, antifolics, mitomycin C) are particularly active when given before the antigenic stimulus, while cyclophosphamide and methyl-hydrazine are especially active after the antigenic stimulus. These results are discussed in relation with the mechanism of immuno-suppression by these products. The indications derived from these results concerning immuno-depressive treatments in Man, and destined at obtaining and maintaining tolerance to incompatible grafts and transplants, are considered.",
author = "Amiel, {J. L.} and M. Sekiguchi and G. Daguet and S. Garattini and V. Palma",
year = "1967",
month = "2",
language = "Francese",
volume = "3",
pages = "47--65",
journal = "European Journal of Cancer",
issn = "0014-2964",
publisher = "Elsevier Ltd",
number = "1",

}

TY - JOUR

T1 - Etude de l'effet immunodépresseur des composés chimiques utilisés en chimiothérapie anticancéreuse

AU - Amiel, J. L.

AU - Sekiguchi, M.

AU - Daguet, G.

AU - Garattini, S.

AU - Palma, V.

PY - 1967/2

Y1 - 1967/2

N2 - The immuno-depressive effect of several compounds: antipurines, antifolics, antipyrimidines, alkylating agents, periwinkle alcaloids, mitomycin C, actinomycin D, puromycin, chloramphenicol, methylhydrazine, imidazoline terephtalanilide, methyl-glyoxal-bis (guanydrazone), epsilon-amino-caproic acid, has been studied in mice by a test including three different antigenic stimuli (human albumen, poliovirus, graft of allogenic skin). They were administered at an infralethal dose, related to the lethal dose in 6 days. The treatment lasted 20 days, ending or beginning on the antigenic day. The results show that, at equal toxicity, the different drugs tested have quite different immuno-depressive activities. Those which interfere with the DNA synthesis (antipurines, antifolics, mitomycin C) are particularly active when given before the antigenic stimulus, while cyclophosphamide and methyl-hydrazine are especially active after the antigenic stimulus. These results are discussed in relation with the mechanism of immuno-suppression by these products. The indications derived from these results concerning immuno-depressive treatments in Man, and destined at obtaining and maintaining tolerance to incompatible grafts and transplants, are considered.

AB - The immuno-depressive effect of several compounds: antipurines, antifolics, antipyrimidines, alkylating agents, periwinkle alcaloids, mitomycin C, actinomycin D, puromycin, chloramphenicol, methylhydrazine, imidazoline terephtalanilide, methyl-glyoxal-bis (guanydrazone), epsilon-amino-caproic acid, has been studied in mice by a test including three different antigenic stimuli (human albumen, poliovirus, graft of allogenic skin). They were administered at an infralethal dose, related to the lethal dose in 6 days. The treatment lasted 20 days, ending or beginning on the antigenic day. The results show that, at equal toxicity, the different drugs tested have quite different immuno-depressive activities. Those which interfere with the DNA synthesis (antipurines, antifolics, mitomycin C) are particularly active when given before the antigenic stimulus, while cyclophosphamide and methyl-hydrazine are especially active after the antigenic stimulus. These results are discussed in relation with the mechanism of immuno-suppression by these products. The indications derived from these results concerning immuno-depressive treatments in Man, and destined at obtaining and maintaining tolerance to incompatible grafts and transplants, are considered.

UR - http://www.scopus.com/inward/record.url?scp=49949145331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49949145331&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:49949145331

VL - 3

SP - 47

EP - 65

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0014-2964

IS - 1

ER -